Identification of cardiometabolic risk: Visceral adiposity index versus triglyceride/HDL cholesterol ratio

American Journal of Medicine

Volumn 127, Issue 2, 2014, Pages 152-157

  Salazar, Martin R ^a   Carbajal, Horacio A ^a   Espeche, Walter G ^a   Aizpurúa, Marcelo ^b   Maciel, Pablo M ^a   Reaven, Gerald M ^c  

^a Hospital Interzonal General de Agudos de La Plata   (Argentina)

^b Hospital Municipal de Rauch   (Argentina)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular outcome; TG HDL C ratio; Visceral adiposity index

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

CARDIOVASCULAR OUTCOME; TG/HDL-C RATIO; VISCERAL ADIPOSITY INDEX;

ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; KAPLAN-MEIER ESTIMATE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84892956946     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.10.012     Document Type: Article

References (17)

1. M.R. Salazar, H.A. Carbajal, and W.G. Espeche et al. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk Diab Vasc Dis Res 8 2 2011 109 116
2. M.R. Salazar, H.A. Carbajal, and W.G. Espeche et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio. insulin resistance and associated cardio-metabolic risk factors in men and women Am J Cardiol 109 2012 1749 1753
3. M.R. Salazar, H.A. Carbajal, and W.G. Espeche et al. Cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria J Intern Med 273 6 2013 595 601
4. M.R. Salazar, H.A. Carbajal, and W.G. Espeche et al. Comparison of the abilities of the plasma triglyceride/high density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance Diab Vasc Dis Res 10 2013 346 352
5. K.G. Alberti, R.H. Eckel, and S.M. Grundy et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity Circulation 120 2009 1640 1645
6. M.C. Amato, C. Giordano, and M. Galia et al. Visceral adiposity index. A reliable indicator of visceral fat function associated with cardiometabolic risk Diabetes Care 33 2010 920 922
7. A. Ciresi, M.C. Amato, G. Pizzolanti, and C. Giordano Galluzzo Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients J Clin Endocrinol Metab 97 8 2012 2907 2915
8. N.M. Al-Daghri, O.S. Al-Attas, and M.S. Alikail et al. Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances Eur J Cin Invest 43 2 2013 183 189
9. J.Y. Oh, Y.A. Sung, and H.J. Lee The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome Obesity 21 2013 1690 1694
10. M.R. Salazar, H.A. Carbajal, and M. Aizpurúa et al. Decrease of blood pressure by community-based strategies Medicina (B Aires) 65 6 2005 507 512
11. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
12. D.R. Matthews, J.P. Hosker, and A.S. Rudenski et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
13. M.C. Amato, and C. Giordano Clinical indications and proper use of Visceral Adiposity Index Nutr Metab Cardiovasc Dis 23 2013 e31 e32
14. M.C. Amato, C. Giordano, M. Pitrone, and A. Galluzzo Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population Lipids Health Dis 10 2011 183
15. B. Mohammadreza, H. Farzad, K. Davoud, and A.F. Fereidoun Prof Prognostic significance of the complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study Cardiovasc Diabetol 11 2012 20
16. J.K. Ninomiya, G. L'Italien, and M.H. Criqui et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey Circulation 109 2004 42 46
17. D. Wormser, S. Kaptoge, and E. Di Angelantonio et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies Lancet 377 2011 1085 1095